Pubblicazioni

Clinical and Prognostic Features of Essential Thrombocythemia: Comparison of 2001 WHO Versus 2008/2016 WHO Criteria in a Large Single-center Cohort

2021 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Chiatamone Ranieri, S.; Arleo, M. A.; Trasarti, S.; Bizzoni, L.; Carmosino, I.; De Luca, M. L.; Mohamed, S.; Mariggio, E.; Scalzulli, E.; Rosati, S.; De Benedittis, D.; Colafigli, G.; Pepe, S.; Molica, M.; Scamuffa, M. C.; Di Prima, A.; Ferretti, A.; Baldacci, E.; Mancini, M.; Santoro, C.; Vignetti, M.; Breccia, M.; Latagliata, R.

BCL2 Expression in First-Line Diffuse Large B-Cell Lymphoma Identifies a Patient Population With Poor Prognosis

2021 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Punnoose, Elizabeth; Peale, Franklin V; Szafer-Glusman, Edith; Lei, Guiyuan; Bourgon, Richard; Do, An D; Kim, Eugene; Zhang, Liping; Farinha, Pedro; Gascoyne, Randy D; Munoz, F Javier; Martelli, Maurizio; Mottok, Anja; Salles, Gilles A; Sehn, Laurie H; Seymour, John F; TrnÄnÃ½, Marek; Oestergaard, Mikkel Z; Mundt, Kirsten E; Vitolo, Umberto

Clinical and Prognostic Features of Essential Thrombocythemia: Comparison of 2001 WHO Versus 2008/2016 WHO Criteria in a Large Single-center Cohort

2021 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Ranieri, Sofia Chiatamone; Arleo, Maria Antonietta; Trasarti, Stefania; Bizzoni, Luisa; Carmosino, Ida; De Luca, Maria Lucia; Mohamed, Sara; Mariggio, Elena; Scalzulli, Emilia; Rosati, Serena; De Benedittis, Daniela; Colafigli, Gioia; Pepe, Sara; Molica, Matteo; Scamuffa, Maria Cristina; Di Prima, Alessio; Ferretti, Antonietta; Baldacci, Emilia; Mancini, Marco; Santoro, Cristina; Vignetti, Marco; Breccia, Massimo; Latagliata, Roberto

Asciminib Provides Durable Responses and a Favorable Safety Profile in Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) with the T315I Mutation in a Phase 1 Study

2021 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Cortes, Jorge E.; Hughes, Timothy P.; Mauro, Michael J.; Hochhaus, Andreas; Rea, Delphine; Goh, Yeow-Tee; Janssen, J. J. W. M.; Heinrich, Michael C.; Talpaz, Moshe; Etienne, Gabriel; Breccia, Massimo; Deininger, Michael; Le Coutre, Philipp; Lang, Fabian; Polydoros, Fotis; Cacciatore, Silvia; Stenson, Laura; Kim, Dong-Wook

Effect of Comorbidities on Response Outcomes with First-Line Tyrosine Kinase Inhibitors (TKIs), Dasatinib Versus Imatinib, in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Exploratory Post Hoc Analysis of DASISION

2021 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Breccia, Massimo; Mauro, Michael; Jabbour, Elias; Saglio, Giuseppe; Jimenez-Velasco, Antonio; le Coutre, Philipp; Degutis, Irene; Khan, Wasiulla; Sy, Oumar; Swanink, Rene; Cortes, Jorge E.

IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study

2021 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Lawless, S; Sbianchi, G; Morris, C; Iacobelli, S; Bosman, P; Blaise, D; Remenyi, P; Byrne, Jl; Mayer, J; Apperley, J; Lund, J; Kobbe, G; Schaap, N; Isaksson, C; Lenhoff, S; Basak, G; Touzeau, C; Wilson, Kmo; Muniz, Sg; Scheid, C; Browne, P; Anagnostopoulos, A; Rambaldi, A; Jantunen, E; Kroger, N; Schonland, S; Yakoub-Agha, I; Garderet, L